1 / 7

Endocrine Testing Market Size, Future Trends, Segmentation

This study gives data on patterns and improvements, and spotlights on Markets and materials, limits and on the changing structure of the Endocrine Testing Market. The key motivation behind the report is to give a proper and key examination of this industry.<br>

shabaz
Télécharger la présentation

Endocrine Testing Market Size, Future Trends, Segmentation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Endocrine Testing Market To Reach USD 15.09 Billion By 2026

  2. Market Summary Endocrine Testing Market Market Size – USD 8.03 Billion in 2018, Market Growth - CAGR of 8.1%, Market Trends – Product launches and research for advanced and precise Endocrine Testing The Global Endocrine Testing market was valued at USD 8.03 billion in 2018 and is expected to reach USD 15.09 billion by year 2026, at a CAGR of 8.1%. Endocrine testing involves examining urine or blood samples to detect the concentration of endocrinal hormones such as thyroid, diabetes, Cushing syndrome, etc. Technological Advancements in terms of accuracy, affordability, cost-effectiveness, and introduction of easy-to-operate test kits have facilitated the penetration of home-based diagnostics.

  3. Our Approach Our Approach Market Summary Increasing incidence of diabetes, sedentary lifestyle, growing healthcare awareness, increasing government support & obesity are some of the key factors projected to surge the demand for Endocrine testing, thereby propelling the market growth. Furthermore, a high prevalence of hyperthyroidism, hypothyroidism, and rising geriatric population are some of the key factors responsible for fueling market growth. In context to regional analysis, the North American region dominated the market in 2018 and is expected to maintain its lead during the forecast period while the Asia Pacific region is projected to witness the fastest growth with a CAGR of 9.1% during the forecast period. Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/2240

  4. Our Approach Our Approach Market Summary Further key findings from the report suggest • Various market players are engaged in developing new products. For instance, Helmholtz Zentrum München allied with Eli Lilly and Company to discover new targets for pancreatic beta cell regeneration in the treatment of diabetes Sensors Segment is expected to witness lucrative growth with a CAGR of 8.6% during the forecast period As of 2018, Tandem Mass Spectrometry segment dominated the market with a market share of 33.9% and is expected to maintain its lead due to its increasing use in combination with liquid chromatography which aids in overcoming challenges associated with traditional techniques in Endocrine testing The Insulin test segment is expected to register fastest growth with a CAGR of 8.8% during the forecast period • • • To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report- detail/endocrine-testing-market

  5. Our Approach Our Approach Market Summary The key players are AB Sciex, Abbott Laboratories, Beckman Coulter, bioMerieux SA, BioRad Laboratories, Biomedical Technologies, Agilent Technologies, Quest Diagnostics, Diasorin, Hoffmann- La Roche Ltd., Thermo Fisher Scientific, Quest Diagnostics and Siemens Healthineers. For the purpose of this report, Reports and Data has segmented the market on the basis of source, product, application, and region: Test Type (Revenue, USD Million; 2016–2026) Estradiol TSH Insulin Cortisol FSH hCG LH DHEAS Progesterone Testosterone Prolactin Others

  6. Our Approach Our Approach Technology Type (Revenue, USD Million; 2016–2026) Tandem Mass Spectrometry Immunoassay Monoclonal & Polyclonal antibody technologies Sensor technology Clinical chemistry Others End Use (Revenue, USD Million; 2016–2026) Hospital Commercial Laboratory Ambulatory Care Centres Others Order Now: https://www.reportsanddata.com/checkout-form/2233

  7. About Us Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related